US20020164812A1
(en)
*
|
1999-04-06 |
2002-11-07 |
Uab Research Foundation |
Method for screening crystallization conditions in solution crystal growth
|
US7247490B2
(en)
*
|
1999-04-06 |
2007-07-24 |
Uab Research Foundation |
Method for screening crystallization conditions in solution crystal growth
|
JP3866043B2
(ja)
*
|
1999-04-06 |
2007-01-10 |
ザ ユーエービー リサーチ ファウンデイション |
溶液結晶成長における結晶化条件をスクリーニングする方法
|
US7214540B2
(en)
*
|
1999-04-06 |
2007-05-08 |
Uab Research Foundation |
Method for screening crystallization conditions in solution crystal growth
|
US7250305B2
(en)
*
|
2001-07-30 |
2007-07-31 |
Uab Research Foundation |
Use of dye to distinguish salt and protein crystals under microcrystallization conditions
|
US7244396B2
(en)
*
|
1999-04-06 |
2007-07-17 |
Uab Research Foundation |
Method for preparation of microarrays for screening of crystal growth conditions
|
US6630006B2
(en)
*
|
1999-06-18 |
2003-10-07 |
The Regents Of The University Of California |
Method for screening microcrystallizations for crystal formation
|
US6975924B2
(en)
*
|
1999-12-03 |
2005-12-13 |
Baxter International Inc. |
Method and apparatus for controlling the strategy of compounding pharmaceutical admixtures
|
US6977723B2
(en)
|
2000-01-07 |
2005-12-20 |
Transform Pharmaceuticals, Inc. |
Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
|
US7108970B2
(en)
*
|
2000-01-07 |
2006-09-19 |
Transform Pharmaceuticals, Inc. |
Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
|
US20070020662A1
(en)
*
|
2000-01-07 |
2007-01-25 |
Transform Pharmaceuticals, Inc. |
Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
|
US20070021929A1
(en)
*
|
2000-01-07 |
2007-01-25 |
Transform Pharmaceuticals, Inc. |
Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
|
US20050095696A9
(en)
*
|
2000-01-07 |
2005-05-05 |
Lemmo Anthony V. |
Apparatus and method for high-throughput preparation and characterization of compositions
|
GB0008563D0
(en)
*
|
2000-04-07 |
2000-05-24 |
Cambridge Discovery Chemistry |
Investigating different physical and/or chemical forms of materials
|
EP1172646A1
(en)
*
|
2000-07-13 |
2002-01-16 |
Universiteit Leiden |
Screening crystallisation conditions of organic compounds
|
US20080182293A1
(en)
*
|
2000-07-14 |
2008-07-31 |
Transform Pharmaceuticals, Inc. |
Computerized control of high-throughput transdermal experimental processing and digital analysis of comparative samples
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6750064B2
(en)
*
|
2000-12-28 |
2004-06-15 |
S.S.C.I. Inc. |
Methods of screening for possible solid forms
|
US7670429B2
(en)
*
|
2001-04-05 |
2010-03-02 |
The California Institute Of Technology |
High throughput screening of crystallization of materials
|
US20060129329A1
(en)
*
|
2001-04-09 |
2006-06-15 |
Kobylecki Ryszard J |
Investigating different physical and/or chemical forms of materials
|
US6733586B2
(en)
|
2001-07-31 |
2004-05-11 |
Illinois Institute Of Technology |
High throughput non-photochemical laser induced nucleation
|
EP1467205A1
(en)
*
|
2001-08-10 |
2004-10-13 |
Symyx Technologies |
Polymorph characterization
|
US20030118078A1
(en)
*
|
2001-08-10 |
2003-06-26 |
Carlson Eric D. |
Apparatuses and methods for creating and testing pre-formulations and systems for same
|
WO2003023409A2
(en)
*
|
2001-09-07 |
2003-03-20 |
Transform Pharmaceuticals, Inc. |
Apparatus and method for high-throughput preparation and characterization of compositions
|
BR0212833A
(pt)
*
|
2001-09-26 |
2004-10-13 |
Baxter Int |
Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
|
JP3759891B2
(ja)
*
|
2001-09-27 |
2006-03-29 |
独立行政法人理化学研究所 |
タンパク質の結晶化方法及び装置
|
EP1308716A1
(en)
*
|
2001-10-03 |
2003-05-07 |
Avantium International B.V. |
Method for performing a transmission diffraction analysis
|
WO2003033462A2
(en)
*
|
2001-10-15 |
2003-04-24 |
The Regents Of The University Of Michigan |
Systems and methods for the generation of crystalline polymorphs
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
US6881363B2
(en)
*
|
2001-12-07 |
2005-04-19 |
Symyx Technologies, Inc. |
High throughput preparation and analysis of materials
|
US6860940B2
(en)
*
|
2002-02-11 |
2005-03-01 |
The Regents Of The University Of California |
Automated macromolecular crystallization screening
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
WO2004061433A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7446107B2
(en)
|
2002-02-15 |
2008-11-04 |
Transform Pharmaceuticals, Inc. |
Crystalline forms of conazoles and methods of making and using the same
|
WO2004078163A2
(en)
*
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
US20050025791A1
(en)
*
|
2002-06-21 |
2005-02-03 |
Julius Remenar |
Pharmaceutical compositions with improved dissolution
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US6919556B1
(en)
|
2002-02-22 |
2005-07-19 |
Monocle Technologies, Inc. |
System and method for monitoring and evaluating solid and semi-solid materials
|
JP4906233B2
(ja)
|
2002-03-01 |
2012-03-28 |
ユニバーシティー オブ サウス フロリダ |
少なくとも1種の有効薬剤成分を含有する多構成要素固相
|
GB0206819D0
(en)
*
|
2002-03-22 |
2002-05-01 |
Univ Glasgow |
A crystallisation system and method
|
US6968037B2
(en)
|
2002-04-10 |
2005-11-22 |
Bristol-Myers Squibb Co. |
High throughput X-ray diffraction filter sample holder
|
US7205413B2
(en)
|
2002-05-03 |
2007-04-17 |
Transform Pharmaceuticals, Inc. |
Solvates and polymorphs of ritonavir and methods of making and using the same
|
DE60332339D1
(de)
*
|
2002-05-07 |
2010-06-10 |
Univ New York State Res Found |
"High througput" Methode, um Biomolekülanlieferung Formulierungen zu kennzeichnen
|
US20070026528A1
(en)
*
|
2002-05-30 |
2007-02-01 |
Delucas Lawrence J |
Method for screening crystallization conditions in solution crystal growth
|
AU2003243354A1
(en)
|
2002-05-31 |
2003-12-19 |
Transform Pharmaceuticals, Inc. |
Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
US20050233461A1
(en)
*
|
2002-06-05 |
2005-10-20 |
Douglas Levinson |
High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders
|
WO2004005898A1
(en)
*
|
2002-07-10 |
2004-01-15 |
Uab Research Foundation |
Method for distinguishing between biomolecule and non-biomolecule crystals
|
AU2003302162A1
(en)
*
|
2002-08-05 |
2004-07-09 |
Baxter International Inc. |
Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7270952B2
(en)
*
|
2002-09-24 |
2007-09-18 |
Intel Corporation |
Detecting molecular binding by monitoring feedback controlled cantilever deflections
|
US20100210027A9
(en)
*
|
2002-11-04 |
2010-08-19 |
Hongming Chen |
Method for determining effect of preformulation forms on their dissolution rates
|
AU2003285143A1
(en)
*
|
2002-11-04 |
2004-06-07 |
Transform Pharmaceuticals, Inc. |
Analysis of pharmaceutical solubility and stability
|
WO2004042327A2
(en)
*
|
2002-11-04 |
2004-05-21 |
Transform Pharmaceuticals, Inc. |
Method and apparatus for manipulating and measuring solids
|
FR2849029B1
(fr)
|
2002-12-20 |
2005-03-18 |
Lafon Labor |
Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
EP1579198A1
(en)
*
|
2002-12-30 |
2005-09-28 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US7452555B2
(en)
|
2003-01-21 |
2008-11-18 |
S.S.C.I., Inc. |
Cocrystallization
|
ATE550022T1
(de)
*
|
2003-02-28 |
2012-04-15 |
Mcneil Ppc Inc |
Pharmazeutische mischkristalle von celecoxib- nicotinamid
|
US7024955B2
(en)
*
|
2003-03-01 |
2006-04-11 |
Symyx Technologies, Inc. |
Methods and systems for dissolution testing
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
JP2007502329A
(ja)
*
|
2003-05-23 |
2007-02-08 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
セルトラリン組成物
|
US20040241742A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Peck Bill J. |
Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
|
US20040241668A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Amorese Douglas A. |
Ligand array assays that include a low surface tension fluid wash step and compositions for practicing the same
|
US20040241880A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Leproust Eric M. |
Ligand array assays having reduced fluorescent dye degradation and compositions for practicing the same
|
UA83504C2
(en)
*
|
2003-09-04 |
2008-07-25 |
Селджин Корпорейшн |
Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
US7223761B2
(en)
*
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
WO2005037424A1
(en)
*
|
2003-10-06 |
2005-04-28 |
Solvias Ag |
Process for the parallel detection of crystalline forms of molecular solids
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
EP1711163A2
(en)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
US20070173536A1
(en)
*
|
2004-02-06 |
2007-07-26 |
Ciba Specialty Chemicals Holding Inc. |
Crystalline forms of zolmitriptan
|
EP2292585B1
(en)
|
2004-03-12 |
2016-04-27 |
Aptuit (West Lafayette), LLC |
Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound
|
US7541357B2
(en)
|
2004-07-15 |
2009-06-02 |
Amr Technology, Inc. |
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
JP4648398B2
(ja)
*
|
2004-11-12 |
2011-03-09 |
シンジェンタ リミテッド |
高速大量処理モードにおける製剤の調合及び特性評価
|
US20060140821A1
(en)
*
|
2004-12-17 |
2006-06-29 |
Rosso Victor W |
Powder X-ray diffraction sample holder
|
US20090208919A1
(en)
*
|
2005-01-21 |
2009-08-20 |
Argylla Technologies, Llp |
Particle matrix for storage of biomolecules
|
WO2006084058A2
(en)
|
2005-02-03 |
2006-08-10 |
The General Hospital Corporation |
Method for treating gefitinib resistant cancer
|
WO2006114705A1
(en)
*
|
2005-04-27 |
2006-11-02 |
Warner-Lambert Company Llc |
Automated birefringence analysis and targeting system
|
AR057649A1
(es)
*
|
2005-05-27 |
2007-12-12 |
Wyeth Corp |
Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
BRPI0612071A2
(pt)
*
|
2005-06-14 |
2010-10-19 |
Baxter Int |
formulações farmacêuticas para minimizar interações entre fármacos
|
US7722838B2
(en)
*
|
2005-07-19 |
2010-05-25 |
Grahn - Monde Groupe De Reflexion & D'action |
System and device for prevention and neutralization of bioactive substances and generating an aroma-producing substance
|
EP1951235B1
(en)
*
|
2005-09-20 |
2010-03-10 |
Scinopharm Singapore Pte, Ltd. |
Novel crystal forms of irinotecan hydrochloride
|
WO2007056118A1
(en)
|
2005-11-04 |
2007-05-18 |
Wyeth |
Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
|
SI2395002T1
(sl)
|
2005-11-08 |
2014-10-30 |
Vertex Pharmaceuticals Incorporated |
Farmacevtski sestavek, vsebujoč heterociklični modulator prenašalcev z ATP-vezavno kaseto
|
JP2009516003A
(ja)
*
|
2005-11-15 |
2009-04-16 |
バクスター・インターナショナル・インコーポレイテッド |
リポキシゲナーゼ阻害剤の組成物
|
WO2007069254A2
(en)
*
|
2005-12-14 |
2007-06-21 |
Makhteshim Chemical Works Ltd. |
POLYMORPHS AND AMORPHOUS FORMS OF 5-AMINO-l-[2,6- DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-4- [(TRIFLUOROMETHYL)SULFINYL]-IH-PYRAZOLE-3-CARBONITRILE
|
GB0525559D0
(en)
*
|
2005-12-15 |
2006-01-25 |
Oxford Diffraction Ltd |
In-situ crystalline material screening apparatus and method
|
GB0601406D0
(en)
*
|
2006-01-24 |
2006-03-08 |
Novartis Ag |
Organic Compounds
|
GB0602778D0
(en)
*
|
2006-02-10 |
2006-03-22 |
Glaxo Group Ltd |
Novel compound
|
US7471386B2
(en)
|
2006-02-27 |
2008-12-30 |
Chemimage Corporation |
System and method for spectral unmixing in a fiber array spectral translator based polymorph screening system
|
US7629591B2
(en)
*
|
2006-03-02 |
2009-12-08 |
Chemimage Corporation |
System and method for structured illumination and collection for improved optical confocality of raman fiber array spectral translator imaging and interactive raman probing
|
US8158957B2
(en)
|
2006-03-02 |
2012-04-17 |
Chemimage Corporation |
System and method for structured illumination and collection for improved optical confocality of raman fiber array spectral translator imaging and interactive raman probing
|
WO2007103894A2
(en)
*
|
2006-03-03 |
2007-09-13 |
Chemimage Corporation |
System and method for fiber array spectral translator based polymorph screening
|
WO2007109651A2
(en)
*
|
2006-03-20 |
2007-09-27 |
Worcester Polytechnic Institute |
Selective growth of stable polymorphs
|
NZ573360A
(en)
|
2006-05-04 |
2012-08-31 |
Boehringer Ingelheim Int |
Polymorphic forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
US7840300B2
(en)
*
|
2006-05-31 |
2010-11-23 |
Robert Arthur Harker |
Full spectrum lapidary 3D image scanner and method
|
NZ574654A
(en)
*
|
2006-07-25 |
2012-03-30 |
Abbott Lab |
Crystalline forms of rapamycin analogs
|
KR101667534B1
(ko)
*
|
2006-09-22 |
2016-10-19 |
씨아이피엘에이 엘티디. |
리팍시민
|
WO2008039472A2
(en)
*
|
2006-09-26 |
2008-04-03 |
Taro Pharmaceuticals North America, Inc. |
Stabilizing compositions for antibiotics and methods of use
|
EP1923053A1
(en)
|
2006-09-27 |
2008-05-21 |
Novartis AG |
Pharmaceutical compositions comprising nilotinib or its salt
|
MX2009003299A
(es)
*
|
2006-09-28 |
2009-04-09 |
Lundbeck & Co As H |
[2-(6-fluor-1h-indol-3-ilsulfanil)bencil]metilamina para el tratamiento de trastornos afectivos.
|
AR062927A1
(es)
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
EP2118260A2
(en)
*
|
2007-01-16 |
2009-11-18 |
Genvault Corporation |
Nanoparticles useful for biomolecule storage
|
EP2125226A2
(en)
*
|
2007-01-26 |
2009-12-02 |
Biodot, Inc. |
Non-contact positive dispense solid powder sampling apparatus and method
|
JP4674910B2
(ja)
*
|
2007-03-29 |
2011-04-20 |
セキテクノトロン株式会社 |
ラマン分光法による結晶多形の自動判定方法及びその装置
|
NZ580126A
(en)
†
|
2007-04-05 |
2012-03-30 |
Pfizer Prod Inc |
Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
|
US20090081721A1
(en)
*
|
2007-04-11 |
2009-03-26 |
The Regents Of The University Of California |
High-throughput cell assays
|
US8037945B2
(en)
*
|
2007-04-13 |
2011-10-18 |
Savannah River Nuclear Solutions, Llc |
Atomic force microscope with combined FTIR-Raman spectroscopy having a micro thermal analyzer
|
JP5497633B2
(ja)
|
2007-05-09 |
2014-05-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Cftrのモジュレーター
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8018588B2
(en)
*
|
2007-06-06 |
2011-09-13 |
Aptuit, Inc. |
Sample holder and sample preparation device
|
US20090010388A1
(en)
*
|
2007-06-06 |
2009-01-08 |
Stahly Barbara C |
Microplate and methods of using the same
|
DE102007034854A1
(de)
*
|
2007-07-24 |
2009-01-29 |
Jpk Instruments Ag |
Verfahren und Vorrichtung zur automatisierten Messung und Kombination von Bildaufnahme und Kraftmessung
|
US20090031826A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Dow Global Technologies Inc. |
High-Throughput Sample Preparation and Analysis for Differential Scanning Calorimetry
|
TW201446748A
(zh)
|
2007-08-22 |
2014-12-16 |
Astrazeneca Ab |
環丙基醯胺衍生物
|
EP2044934A1
(en)
*
|
2007-10-01 |
2009-04-08 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof
|
CA2696423A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Guidong Zhu |
2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2
|
CA3006332A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Abbvie Ireland Unlimited Company |
2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
|
US8022216B2
(en)
*
|
2007-10-17 |
2011-09-20 |
Wyeth Llc |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
|
WO2009059605A1
(en)
*
|
2007-11-08 |
2009-05-14 |
University Of Copenhagen |
Small scale solid state screening
|
US20090155920A1
(en)
*
|
2007-11-12 |
2009-06-18 |
Symyx Technologies, Inc. |
High throughput dissolution and precipitation apparatus and method
|
SI2225230T1
(sl)
|
2007-12-07 |
2017-03-31 |
Vertex Pharmaceuticals Incorporated |
Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline
|
PL2639223T3
(pl)
|
2007-12-07 |
2017-09-29 |
Vertex Pharmaceuticals Incorporated |
Sposób wytwarzania kwasów cykloalkilokarboksyamido-pirydyno-benzoesowych
|
JP5535082B2
(ja)
*
|
2008-01-01 |
2014-07-02 |
シプラ・リミテッド |
ボセンタン、その多形形態及びその塩の合成方法
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
BRPI0908864A2
(pt)
|
2008-02-25 |
2018-09-18 |
Salix Pharmaceuticals Ltd |
formas da rifaximina e usos das mesmas
|
CA2931134C
(en)
|
2008-02-28 |
2019-07-30 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl derivatives as cftr modulators
|
US20090218489A1
(en)
*
|
2008-02-28 |
2009-09-03 |
Douglas William Akers |
Systems and methods for material treatment and characterization employing positron annihilation
|
US8975410B2
(en)
*
|
2008-03-17 |
2015-03-10 |
BIAL—Portela & CA., S.A. |
Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol
|
CN102046202A
(zh)
*
|
2008-03-26 |
2011-05-04 |
塔罗制药北美有限公司 |
用于口服药剂的稳定脂质组合物
|
WO2009120841A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Bristol-Myers Squibb Company |
Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate
|
AR071175A1
(es)
|
2008-04-03 |
2010-06-02 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
AR071997A1
(es)
*
|
2008-06-04 |
2010-07-28 |
Bristol Myers Squibb Co |
Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
|
EP2915532B1
(en)
|
2008-06-17 |
2016-10-19 |
Wyeth LLC |
Antineoplastic combinations containing hki-272 and vinorelbine
|
US20100011889A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Biodot, Inc. |
Handheld powder handling devices and related methods
|
TWI472521B
(zh)
*
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
(2s,3r,4r,5s,6r)-2-(4-氯-3-(4-乙氧苄基)苯基)-6-(甲硫)四氫-2h-哌喃-3,4,5-三醇的固體形態與其使用方法
|
ES2614912T3
(es)
|
2008-08-04 |
2017-06-02 |
Wyeth Llc |
Combinaciones antineoplásicas de 4-anilino-3-cianoquinolinas y capecitabina
|
KR20190016601A
(ko)
|
2008-08-06 |
2019-02-18 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
TW201016675A
(en)
*
|
2008-09-16 |
2010-05-01 |
Mitsubishi Tanabe Pharma Corp |
Crystalline benzoimidazole compound and salt thereof
|
NZ602163A
(en)
*
|
2008-09-16 |
2013-06-28 |
Boehringer Ingelheim Int |
Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hepatitis c viral inhibitor
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
TWI508965B
(zh)
*
|
2008-12-23 |
2015-11-21 |
Boehringer Ingelheim Int |
有機化合物的鹽形式
|
JP5289989B2
(ja)
*
|
2009-01-27 |
2013-09-11 |
日本分光株式会社 |
位相差測定装置
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
EP3000467B1
(en)
|
2009-04-06 |
2023-03-01 |
Wyeth LLC |
Treatment regimen utilizing neratinib for breast cancer
|
CN102458123A
(zh)
|
2009-05-12 |
2012-05-16 |
阿尔巴尼分子研究公司 |
芳基、杂芳基和杂环取代的四氢异喹啉及其用途
|
US20110066386A1
(en)
*
|
2009-09-16 |
2011-03-17 |
Chien-Chong Hong |
Anesthetic sensing optical microfluidic chip system
|
FR2951171A1
(fr)
*
|
2009-10-09 |
2011-04-15 |
Novexel |
Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
|
PL3133070T3
(pl)
*
|
2009-11-27 |
2020-01-31 |
Genzyme Corporation |
Eliglustat (Genz 112638) jako inhibitor syntazy glukozyloceramidowej do zastosowania w sposobie leczenia choroby Fabry’ego lub choroby Gauchera, przy czym sposób obejmuje dostosowanie indywidualnej dawki terapeutycznej do metabolizmu P450 u pacjenta
|
JP2013512229A
(ja)
|
2009-11-27 |
2013-04-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療
|
BR112012020629A2
(pt)
*
|
2010-02-18 |
2018-06-19 |
Astrazeneca Ab |
forma cristalina, e, método para a terapia de um distúrbio
|
CA2789884A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Astrazeneca Ab |
Solid forms comprising a cyclopropyl amide derivative
|
GB201004677D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Vantia Ltd |
New salt
|
KR20160062208A
(ko)
*
|
2010-03-23 |
2016-06-01 |
시가 테크놀로지스, 인크. |
다형체 형태 st―246 및 제조방법
|
JP2013523833A
(ja)
|
2010-04-07 |
2013-06-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
3−(6−(1−(2,2−ジフルオロベンゾ[d][1,3]ジオキソール−5−イル)シクロプロパンカルボキサミド)−3−メチルピリジン−2−イル)安息香酸の医薬組成物およびその投与
|
NZ602921A
(en)
|
2010-05-05 |
2016-01-29 |
Boehringer Ingelheim Int |
Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
|
US8841476B2
(en)
*
|
2010-06-07 |
2014-09-23 |
Telik, Inc. |
Preparation of crystalline ezatiostat hydrochloride ansolvate form D
|
MX2012014247A
(es)
|
2010-06-24 |
2013-01-18 |
Boehringer Ingelheim Int |
Terapia para la diabetes.
|
JP5780721B2
(ja)
*
|
2010-08-06 |
2015-09-16 |
日京テクノス株式会社 |
タンパク質結晶成長装置、及びその方法
|
TW201221128A
(en)
*
|
2010-09-01 |
2012-06-01 |
Portola Pharm Inc |
Crystalline forms of a factor Xa inhibitor
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
US8987285B2
(en)
*
|
2010-12-03 |
2015-03-24 |
Portola Pharmaceuticals, Inc. |
Pharmaceutical compositions, dosage forms and new forms of the compound of formula (I), and methods of use thereof
|
TWI530489B
(zh)
*
|
2011-03-22 |
2016-04-21 |
必治妥美雅史谷比公司 |
雙(氟烷基)-1,4-苯二氮呯酮化合物
|
DE102011103751A1
(de)
*
|
2011-05-31 |
2012-12-06 |
Heraeus Precious Metals Gmbh & Co. Kg |
Kristallisierung von Epirubicinhydrochlorid
|
US9174983B2
(en)
*
|
2011-06-16 |
2015-11-03 |
Mitsubishi Gas Chemical Company, Inc. |
Pyrroloquinoline quinone disodium salt crystal and method for producing the same
|
CA2843777C
(en)
*
|
2011-07-08 |
2018-11-06 |
Sanofi |
Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
|
IN2014CN00817A
(pt)
*
|
2011-07-08 |
2015-04-03 |
Sanofi Sa |
|
EP3517539B1
(en)
|
2011-07-15 |
2022-12-14 |
Boehringer Ingelheim International GmbH |
Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
|
WO2013019611A1
(en)
*
|
2011-07-29 |
2013-02-07 |
Medicinova, Inc. |
Denibulin di-hydrochloride
|
WO2013109405A1
(en)
*
|
2012-01-17 |
2013-07-25 |
The Scripps Research Institute |
Preparation of specimen arrays on an em grid
|
DK2807178T3
(en)
*
|
2012-01-26 |
2017-09-04 |
Inotek Pharmaceuticals Corp |
Anhydrous polymorphs of (2R, 3S, 4R, 5R) -5- (6- (cyclopentylamino) -9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl nitrate and processes for their preparation
|
BR112014021935A2
(pt)
|
2012-03-05 |
2019-09-24 |
Gilead Calistoga Llc |
formas polimórficas de (s)-2(l-(9h-purin-6-ilamino)propil)-5-fluoro-3-fenilquinazolina-4(3h)ona
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
CN105949264A
(zh)
|
2012-04-01 |
2016-09-21 |
浙江海正药业股份有限公司 |
人参皂苷c-k的两种晶型及其制备方法
|
CN106008646A
(zh)
|
2012-04-01 |
2016-10-12 |
浙江海正药业股份有限公司 |
人参皂苷c-k化合物多晶型及其制备方法
|
WO2013171167A1
(en)
|
2012-05-14 |
2013-11-21 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
US9056860B2
(en)
*
|
2012-06-05 |
2015-06-16 |
Gilead Pharmasset Llc |
Synthesis of antiviral compound
|
CN104603138A
(zh)
*
|
2012-07-12 |
2015-05-06 |
艾伯维公司 |
Hcv抑制剂的晶形
|
CN103539783A
(zh)
*
|
2012-07-12 |
2014-01-29 |
江苏恒瑞医药股份有限公司 |
一种酪氨酸激酶抑制剂的二马来酸盐的i型结晶及制备方法
|
AU2013293973B2
(en)
*
|
2012-07-25 |
2017-04-06 |
Fujiyakuhin Co., Ltd. |
4-[5-(Pyridin-4-yl)-1H-1,2,4-Triazol-3-yl]Pyridine-2-Carbonitrile Crystalline Polymorph and Production Method Therefor
|
CN102746258B
(zh)
*
|
2012-07-25 |
2015-02-04 |
重庆泰濠制药有限公司 |
卡巴他赛的结晶形式及其制备方法
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
AP2015008721A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
PE20160078A1
(es)
|
2013-03-15 |
2016-03-02 |
Global Blood Therapeutics Inc |
Compuestos y sus usos para modular la hemoglobina
|
MY183637A
(en)
|
2013-03-15 |
2021-03-04 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
EP3190102B1
(en)
*
|
2013-04-10 |
2018-09-12 |
Daiichi Sankyo Company, Limited |
CRYSTAL OF (S)-1-(2-HYDROXYETHYL)-4-METHYL-N- [4-(METHYLSULFONYL)PHENYL]-5-[2-(TRIFLUOROMETHYL)& xA;PHENYL]- 1H-PYRROLE-3-CARBOXAMIDE
|
RU2708079C9
(ru)
*
|
2013-06-09 |
2020-02-28 |
Бетта Фармасьютикалз Ко., Лтд |
Полиморфные формы икотиниба малеата и их применения
|
KR102270538B1
(ko)
|
2013-06-09 |
2021-06-29 |
베타 파머수티컬 컴퍼니 리미티드 |
이코티닙 포스페이트의 신규한 다형체 형태 및 이의 용도
|
KR20150001936A
(ko)
*
|
2013-06-28 |
2015-01-07 |
제일약품주식회사 |
게피티닙의 신규한 결정형 및 이의 제조방법
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
DE202013103650U1
(de)
|
2013-08-12 |
2013-09-23 |
Aspect Imaging Ltd. |
Nichtinvasives MRT-System zur Analyse der Qualität von festen Nahrungsmittelprodukten, die von einem flexiblen Aluminiumfolienumschlag umhüllt sind
|
JP5680161B1
(ja)
|
2013-09-06 |
2015-03-04 |
株式会社ポーラファルマ |
晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
|
US20160280731A1
(en)
*
|
2013-11-11 |
2016-09-29 |
Crystal Pharmatech Co., Ltd |
CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN
|
RU2016122882A
(ru)
|
2013-11-12 |
2017-12-19 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения фармацевтических композиций для лечения опосредованных cftr заболеваний
|
TWI788702B
(zh)
*
|
2013-11-15 |
2023-01-01 |
美商阿克比治療有限公司 |
{[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
|
NZ720867A
(en)
|
2013-12-20 |
2018-01-26 |
Gilead Calistoga Llc |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
WO2015095605A1
(en)
|
2013-12-20 |
2015-06-25 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
|
PT3102208T
(pt)
*
|
2014-02-07 |
2021-04-05 |
Global Blood Therapeutics Inc |
Polimorfos cristalinos da base livre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3 il)metoxi)benzaldeído
|
EP3112371A4
(en)
*
|
2014-02-25 |
2017-07-05 |
Daiichi Sankyo Company, Limited |
High-purity crystals of active blood coagulation factor x (fxa) inhibitor
|
US9526728B2
(en)
|
2014-02-28 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Medical use of a DPP-4 inhibitor
|
US9896429B2
(en)
|
2014-05-27 |
2018-02-20 |
R.J. Reynolds Tobacco Company |
Nicotine salts, co-crystals, and salt co-crystal complexes
|
US10508096B2
(en)
|
2014-05-27 |
2019-12-17 |
R.J. Reynolds Tobacco Company |
Nicotine salts, co-crystals, and salt co-crystal complexes
|
EP3871515A1
(en)
|
2014-05-27 |
2021-09-01 |
R. J. Reynolds Tobacco Company |
Nicotine salts, co-crystals, and salt co-crystal complexes
|
US11300531B2
(en)
|
2014-06-25 |
2022-04-12 |
Aspect Ai Ltd. |
Accurate water cut measurement
|
US9687484B2
(en)
|
2014-07-18 |
2017-06-27 |
Dipharma Francis S.R.L. |
Crystalline forms of an antidepressant compound
|
CN105399771B
(zh)
*
|
2014-07-21 |
2020-11-24 |
江苏豪森药业集团有限公司 |
替诺福韦前药晶型及其制备方法和用途
|
CA2966583A1
(en)
|
2014-11-06 |
2016-05-12 |
Lysosomal Therapeutics Inc. |
Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
|
RU2691136C2
(ru)
|
2014-11-18 |
2019-06-11 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ проведения высокопроизводительной тестовой высокоэффективной жидкостной хроматографии
|
KR20170118700A
(ko)
*
|
2014-12-16 |
2017-10-25 |
셀진 코포레이션 |
(1e,4e)-2-아미노-n,n-디프로필-8-(4-(피롤리딘-1-카보닐)페닐)-3h-벤조[b]아제핀-4-카복사미드를 포함하는 고체형, 이의 조성물, 및 이의 용도
|
BR112017013593A2
(pt)
*
|
2014-12-23 |
2018-06-19 |
Cerecor, Inc. |
compostos, composições e métodos
|
JP6428414B2
(ja)
*
|
2015-03-19 |
2018-11-28 |
株式会社島津製作所 |
オートサンプラ
|
PT108370B
(pt)
*
|
2015-03-30 |
2018-10-25 |
Hovione Farm S A |
Processo de preparação de brometo de aclidínio
|
CN105693699B
(zh)
*
|
2015-03-30 |
2019-06-18 |
苏州晶云药物科技股份有限公司 |
托吡司他的晶型及其制备方法
|
US10702517B2
(en)
|
2015-04-22 |
2020-07-07 |
Celgene Quanticel Research, Inc. |
Bromodomain inhibitor
|
CA2990546A1
(en)
*
|
2015-08-10 |
2017-02-16 |
Sandoz Ag |
Form c of avibactam sodium
|
JP6684557B2
(ja)
*
|
2015-08-28 |
2020-04-22 |
国立研究開発法人産業技術総合研究所 |
ナノ粒子のスクリーニング方法及びスクリーニングシステム
|
JP6651310B2
(ja)
*
|
2015-08-28 |
2020-02-19 |
国立研究開発法人産業技術総合研究所 |
ナノ粒子及びその製造方法
|
CN108291872A
(zh)
*
|
2015-08-28 |
2018-07-17 |
国立研究开发法人产业技术综合研究所 |
纳米粒子的筛选方法及筛选系统、与纳米粒子及其制造方法
|
DK3379952T3
(da)
|
2015-11-25 |
2024-01-08 |
Reynolds Tobacco Co R |
Nikotinsalte, co-krystaller og salt-co-krystalkomplekser
|
TW201731509A
(zh)
|
2015-12-04 |
2017-09-16 |
全球血液治療公司 |
針對2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之劑量方案
|
CN113816951B
(zh)
*
|
2015-12-29 |
2022-09-27 |
上海医药集团股份有限公司 |
吗啉衍生物的盐及其晶型、其制备方法及药物组合物、用途
|
US20170275330A1
(en)
*
|
2016-03-28 |
2017-09-28 |
Warsaw Orthopedic, Inc. |
Polymorphic forms of an oxysterol and methods of making them
|
CA3022670A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
|
RU2621187C1
(ru)
*
|
2016-05-13 |
2017-06-01 |
Общество с ограниченной ответственностью "Молекулярные Технологии" |
Новая кристаллическая солевая форма 2,2-диметил-6-((4-((3,4,5-триметоксифенил)амино)-1,3,5-триазин-2-ил)амино)-2н-пиридо[3,2-в][1,4]оксазин-3(4н)-она для медицинского применения
|
EP3468562A1
(en)
|
2016-06-10 |
2019-04-17 |
Boehringer Ingelheim International GmbH |
Combinations of linagliptin and metformin
|
JP6676491B2
(ja)
*
|
2016-07-13 |
2020-04-08 |
株式会社トクヤマ |
アジルサルタンアルキルエステルの製造方法、及びアジルサルタンの製造方法
|
CN109415327A
(zh)
*
|
2016-07-05 |
2019-03-01 |
株式会社德山 |
阿齐沙坦中间体、阿齐沙坦及它们的制造方法
|
EP3273239A1
(en)
*
|
2016-07-19 |
2018-01-24 |
Laboratorios Farmacéuticos Rovi, S.A. |
Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance
|
CN115974954A
(zh)
|
2016-08-23 |
2023-04-18 |
萨奇治疗股份有限公司 |
19-去甲c3,3-二取代的c21-n-吡唑基类固醇的晶体
|
EP3505516B1
(en)
*
|
2016-08-25 |
2021-10-06 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Crystal of salt of quinazoline derivative
|
JP7129973B2
(ja)
*
|
2016-10-20 |
2022-09-02 |
セルジーン クオンティセル リサーチ,インク. |
ブロモドメイン阻害剤
|
US11384114B2
(en)
*
|
2016-12-09 |
2022-07-12 |
Warsaw Orthopedic, Inc. |
Polymorphic forms of an oxysterol and methods of making them
|
CN110139904A
(zh)
*
|
2016-12-30 |
2019-08-16 |
涂层国外知识产权有限公司 |
用于配方信息生成的系统和方法
|
CN106770400B
(zh)
*
|
2017-01-06 |
2023-08-15 |
中国工程物理研究院核物理与化学研究所 |
一种用于小角中子散射谱仪的自动换样装置
|
RU2019123279A
(ru)
*
|
2017-01-26 |
2021-02-26 |
Оно Фармасьютикал Ко., Лтд. |
Этан-сульфонатная соль производного хинолина
|
WO2018151815A1
(en)
*
|
2017-02-17 |
2018-08-23 |
Eidos Therapeutics, Inc. |
Processes for preparing ag-10, its intermediates, and salts thereof
|
US10345251B2
(en)
|
2017-02-23 |
2019-07-09 |
Aspect Imaging Ltd. |
Portable NMR device for detecting an oil concentration in water
|
CN106990075B
(zh)
*
|
2017-03-03 |
2019-07-09 |
西北大学 |
一种用于单个悬浮颗粒的二次谐波成像方法和装置
|
US10625233B2
(en)
*
|
2017-04-04 |
2020-04-21 |
Tannas Company |
Testing pharmaceuticals and related substances
|
KR101856444B1
(ko)
|
2017-04-20 |
2018-05-10 |
압타바이오 주식회사 |
3-페닐-4-프로필-1-(피리딘-2-일)-1h-피라졸-5-올 염산염의 신규 결정형 고체 화합물
|
CN110913861B
(zh)
*
|
2017-06-29 |
2024-01-09 |
G1治疗公司 |
G1t38的形态学形式及其制造方法
|
CA3072030A1
(en)
*
|
2017-08-21 |
2019-02-28 |
Dishman Carbogen Amcis Ltd. |
Octenidine based compounds
|
WO2019049049A1
(en)
|
2017-09-05 |
2019-03-14 |
R. J. Reynolds Tobacco Company |
SALTS, CO-CRYSTALS, AND CO-CRYSTAL COMPLEXES OF NICOTINE SALTS
|
CA3112277A1
(en)
|
2017-09-15 |
2019-03-21 |
Crystal Pharmaceutical (Suzhou) Co., Ltd. |
Crystal form of gsk1278863 and preparation method and pharmaceutical use thereof
|
WO2019074116A1
(ja)
|
2017-10-13 |
2019-04-18 |
小野薬品工業株式会社 |
Axl阻害剤を有効成分として含む固形がん治療剤
|
AU2018378348A1
(en)
*
|
2017-12-05 |
2020-06-18 |
Sunovion Pharmaceuticals Inc. |
Crystal forms and production methods thereof
|
JP2021506926A
(ja)
*
|
2017-12-20 |
2021-02-22 |
サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. |
ピラゾロ[1,5−a]ピリジン誘導体の塩及びその使用
|
WO2019126776A1
(en)
*
|
2017-12-21 |
2019-06-27 |
Lysosomal Therapeutics Inc. |
Crystalline substituted cyclohexyl pyrazolo[1,5-a]pyrimidinyl carboxamide compound and therapeutic uses thereof
|
CN115057815A
(zh)
*
|
2018-03-02 |
2022-09-16 |
正大天晴药业集团股份有限公司 |
作为c-Met激酶抑制剂的化合物的结晶及其制备方法和用途
|
US11542245B2
(en)
|
2018-03-15 |
2023-01-03 |
Bayer Pharma Aktiengesellschaft |
Preparative process
|
US20210018482A1
(en)
*
|
2018-03-19 |
2021-01-21 |
Trustees Of Boston University |
Systems, devices, and methods for ultrasonic agitation mediated kinetic release testing of compounds
|
CN112313223A
(zh)
*
|
2018-05-14 |
2021-02-02 |
阿瑞雅德制药公司 |
嘧啶衍生物的药用盐及治疗病症的方法
|
SG11202013177WA
(en)
*
|
2018-07-04 |
2021-01-28 |
Radius Pharmaceuticals Inc |
Polymorphic forms of rad 1901-2hcl
|
WO2020020969A1
(en)
*
|
2018-07-25 |
2020-01-30 |
Orion Corporation |
4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile solvates and crystalline forms thereof
|
JP2021533154A
(ja)
*
|
2018-08-06 |
2021-12-02 |
アルデイラ セラピューティクス, インコーポレイテッド |
多形化合物およびその使用
|
CN112236413A
(zh)
*
|
2018-08-14 |
2021-01-15 |
努福米克斯技术有限公司 |
结晶曲尼司特盐及其药物用途
|
AU2019346585A1
(en)
*
|
2018-09-26 |
2021-04-29 |
Astrocyte Pharmaceuticals, Inc. |
Polymorphic compounds and uses thereof
|
US11014884B2
(en)
|
2018-10-01 |
2021-05-25 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin
|
JP7400726B2
(ja)
*
|
2018-10-03 |
2023-12-19 |
ソニーグループ株式会社 |
情報処理装置、スケジューリング方法及びプログラム
|
TW202028208A
(zh)
|
2018-10-09 |
2020-08-01 |
瑞士商諾華公司 |
N-(4-氟-3-(6-(3-甲基吡啶-2-基)-[1,2,4]三唑并[1,5-a]嘧啶-2-基)苯基)-2,4-二甲基㗁唑-5-甲醯胺固體形式
|
CN112840209A
(zh)
*
|
2018-10-15 |
2021-05-25 |
株式会社岛津制作所 |
色谱仪控制装置、色谱仪系统、色谱仪控制方法以及色谱仪控制程序
|
AU2019361273A1
(en)
*
|
2018-10-19 |
2021-05-06 |
F. Hoffmann-La Roche Ag |
New forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making
|
US11485754B2
(en)
|
2018-11-01 |
2022-11-01 |
Yamasa Corporation |
Cyclic-di-AMP sodium salt crystal
|
CN109613151A
(zh)
*
|
2018-11-14 |
2019-04-12 |
温州科技职业学院 |
一种检测固态肥料中生长调节剂的预处理方法以及检测液态肥料中生长调节剂的预处理方法
|
KR20210099066A
(ko)
*
|
2018-12-04 |
2021-08-11 |
스미토모 다이니폰 파마 온콜로지, 인크. |
암의 치료를 위한 작용제로서 사용하기 위한 cdk9 억제제 및 그의 다형체
|
CN111285862A
(zh)
*
|
2018-12-07 |
2020-06-16 |
江苏恩华药业股份有限公司 |
一种丙酰胺类衍生物的结晶形式及其制备方法
|
CN109685157A
(zh)
*
|
2019-01-02 |
2019-04-26 |
辽宁工程技术大学 |
一种对结构面产状进行分组的方法
|
WO2020143793A1
(zh)
*
|
2019-01-10 |
2020-07-16 |
石药集团中奇制药技术(石家庄)有限公司 |
杂环化合物盐及其应用
|
KR20210116517A
(ko)
*
|
2019-01-11 |
2021-09-27 |
에일러 파마슈티컬스 아이엔씨. |
케타민 파모에이트 및 이의 용도
|
CN111454318A
(zh)
*
|
2019-01-20 |
2020-07-28 |
浙江易众化工有限公司 |
抗抑郁药物sage-217的晶型及其制备方法
|
AU2020271908A1
(en)
*
|
2019-04-11 |
2021-11-04 |
Mei Pharma, Inc. |
Voruciclib poly morphs and methods of making and using thereof
|
RU2712766C1
(ru)
*
|
2019-04-17 |
2020-01-31 |
федеральное государственное автономное образовательное учреждение высшего образования "Южный федеральный университет" (Южный федеральный университет) |
Способ оценки влияния адсорбирующихся газов на поверхность материалов
|
US11407735B2
(en)
*
|
2019-05-16 |
2022-08-09 |
Novartis Ag |
Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
|
CN114929696A
(zh)
*
|
2019-05-24 |
2022-08-19 |
浙江海正药业股份有限公司 |
丙烯酸类衍生物的晶型及其制备方法和用途
|
AU2020288270B2
(en)
|
2019-06-06 |
2023-07-13 |
Genfleet Therapeutics (Shanghai) Inc. |
Polymorph of CDK9 inhibitor and preparation method for polymorph and use thereof
|
EP3992192A4
(en)
*
|
2019-07-22 |
2022-08-17 |
Guangdong Raynovent Biotech Co., Ltd. |
DOMINANT SALT FORMS OF PYRIMIDINE DERIVATIVES AND CRYSTAL FORMS THEREOF
|
CN112345486B
(zh)
*
|
2019-08-08 |
2022-06-14 |
湖南中烟工业有限责任公司 |
一种基于近红外光谱技术的单体香原料溶液所用溶剂的判定方法
|
US11524939B2
(en)
|
2019-11-13 |
2022-12-13 |
Akebia Therapeutics, Inc. |
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
|
JP7410693B2
(ja)
*
|
2019-11-18 |
2024-01-10 |
花王株式会社 |
ベースメイク塗膜の解析方法
|
CN111455455A
(zh)
*
|
2020-02-29 |
2020-07-28 |
武汉大学 |
具有在线监测功能的晶体生长装置
|
CN111323382B
(zh)
*
|
2020-03-23 |
2023-03-14 |
巴彦淖尔市医院 |
一种前列腺癌治疗药剂的鉴别装备及其方法
|
CN112466413B
(zh)
*
|
2020-12-04 |
2024-04-12 |
南通海智医药科技有限公司 |
小分子药物特定晶形的分子调控方法
|
CN112733137B
(zh)
*
|
2020-12-24 |
2021-11-16 |
哈尔滨工业大学 |
一种面向漏洞检测的二进制代码相似性分析方法
|
WO2023204303A1
(ja)
*
|
2022-04-22 |
2023-10-26 |
大鵬薬品工業株式会社 |
7H-ピロロ[2,3-d]ピリミジン-4-アミン誘導体の結晶
|